Results-Three months after cardioversion percentage fractional shortening had increased by more than 5% in 14 patients (improved group) and by less than 5°in nine patients (non-improved group). Those in whom cardiac function improved had significantly higher heart rates and a greater reduction in ventricular filling during atrial fibrillation and a more prominent atrial filling wave three months after cardioversion than those patients in the non-improved group. Over the three months of follow up the mean (1SD) percentage fractional shortening increased from 22 (3)% to 30 (4)% in the improved group and in this group heart rate fell one day after cardioversion. A month after cardioversion the percentage fractional shortening had increased to 35 (5)% and the atrial systolic contribution to left ventricular filling increased from 30 (9)% on day 1 to 47 (12)%.
Abstract
Objective-To assess the clinical characteristics of patients in whom cardiac function improved after cardioversion of atrial fibrillation and the time course of the improvement. Design-A prospective serial study of echocardiograms recorded before cardioversion and one day, seven days, one month, and three months after cardioversion. Setting-Echocardiography laboratory of a university hospital. Patients-23 patients with chronic atrial fibrillation in whom cardioversion was successful. Main outcome measures-M mode indices of the left ventricular wall motion and pulsed Doppler indices of the left ventricular inflow. Results-Three months after cardioversion percentage fractional shortening had increased by more than 5% in 14 patients (improved group) and by less than 5°in nine patients (non-improved group). Those in whom cardiac function improved had significantly higher heart rates and a greater reduction in ventricular filling during atrial fibrillation and a more prominent atrial filling wave three months after cardioversion than those patients in the non-improved group. Over the three months of follow up the mean (1SD) percentage fractional shortening increased from 22 (3)% to 30 (4)% in the improved group and in this group heart rate fell one day after cardioversion. A month after cardioversion the percentage fractional shortening had increased to 35 (5)% and the atrial systolic contribution to left ventricular filling increased from 30 (9)% on day 1 to 47 (12) %.
Conclusions-Cardioversion improved cardiac function in patients with tachycardia and reduced ventricular filling during atrial fibrillation. Because both an immediate reduction of heart rate and a delayed recovery of atrial booster pump function played an important part in the improvement of cardiac function the long-term effects of cardioversion should be assessed at least a month after cardioversion. (Br Heartj 1993; 70:154-159) Atrial fibrillation is a common cardiac rhythm disorder that affects almost 0 4% of the adult population. It is often accompanied by the symptoms of heart failure, such as dyspnoea, chest discomfort, or fatigue.' So cardioversion of atrial fibrillation is commonly applied to improve cardiac function. But the reported effects of cardioversion on haemodynamic variables are inconsistent. In a total of three studies cardiac output at rest increased in 32 of 46 patients and remained unchanged or became less in the remaining 14.24 This inconsistency may be attributable to variations in the underlying heart disease and in the timing of the evaluation after cardioversion. Because the atrial contribution to ventricular filling is different in each case,5 the response to cardioversion is likely to be heterogeneous. Also the reported delay in the recovery of atrial pump function after cardioversion" may also influence the recovery of ventricular function.
To determine the clinical characteristics of the patients in whom cardiac function improved and to study the time course of such improvement after cardioversion, we used M mode and pulsed Doppler echocardiography to follow the serial changes in left ventricular wall motion and left ventricular filling.
Patients and methods

PATIENTS AND STUDY DESIGN
We studied 23 patients (17 men and 6 women, mean (1SD) age 53 (16) years old (range 24-79)) with chronic atrial fibrillation in whom cardioversion was successful and who remained in sinus rhythm during the observation period. Table 1 shows the clinical characteristics of these 23 patients. The underlying diseases predisposing to atrial fib- Figure 2 shows the changes in percentage fractional shortening before and three months after cardioversion. Percentage fractional shortening increased more than 5% in 14 patients (improved group) and less than 5% in nine patients (non-improved group). Table  2 shows the clinical characteristics of these groups. All the patients with hypertension (4/4), 63% of those with dilated cardiomyopathy (5/8), 60% of those with hypertrophic cardiomyopathy (3/5), 50% of those with no underlying diseases (2/4), and none with old myocardial infarction (0/2) belonged to the improved group. There were no differences in age or duration of atrial fibrillation between the two groups. Figure 3 shows the serial changes in the percentage fractional shortening and heart rate in the improved group. The percentage fractional shortening increased from 22 (3)% to 30 (4)% one day after cardioversion, to 31 (4)% seven days after cardioversion, and to 35 (5)% one month after cardioversion. There were no significant changes from one month to three months. Despite pretreatment with digoxin, heart rate decreased from 93 (21) beats/min to 67 (4) beats/min immediately after cardioversion and remained almost constant through the following observation period. The ratio of peak velocities of the atrial and early filling waves was 0O6 (02) on day one and it gradually increased to 1A4 (05) one month after cardioversion. Concomitantly, late diastolic septal expansion caused by atrial contraction also gradually increased from 0-5 (0-3) mm on day 1 to 2'0 (0-7) mm one month after cardioversion (fig 4) Figure 4 Serial changes in the ratio of the peak velocities of the left atrial and earlyfiUing waves (AIE) and late diastolic septal expansion (LDSE) caused by atrial contraction after cardioversion in 14 patients in whom percentage fractional shortening increased by more than 5% duringfolow up. *p < 0 05 v 1 day after cardioversion; **p < 005 v 7 days after cardioversion. divided into two groups (improved and nonimproved) according to the increase in percentage fractional shortening. We found several differences between these two groups. Before cardioversion the improved groups showed tachycardia and reduced left ventricular filling. These findings suggest that patients in the improved group had benefited more from the reduction of heart rate and the subsequent increase in ventricular filling time than those in the non-improved group. Lewis also reported that tachycardia was a major factor in depressing the left ventricular function during atrial fibrillation and that the recovery of cardiac function was dependent on heart rate.'5 Augmentation of total left ventricular filling with increased filling time played an improtant part in in£reasing percentage fractional shortening.
Moreover the prominent contribution of atrial systole to the total left ventricular filling in the improved group a month after cardioversion suggested that the atrial booster pump function also played an important part in recovery. Gesell showed that an appropriately timed atrial systole increased cardiac output by 30%.'6 Wiggers and Katz, using a cardiometer, showed that atrial systole contributed 18-60% of the total volume of blood that entered the ventricle during diastole. The Days after cardioversion Figure 5 Our data showed that percentage fractional shortening had increased from 22% to 30% a day after cardioversion and the heart rate had fallen from 93 beats/min to 67 beats/min. The mechanism responsible for the initial increase in percent fractional shortening was thought to be the reduction in heart rate.
Our results showed a further increase in the percentage fractional shortening from 30% on day 1 to 35% a month after cardioversion. This delayed recovery of cardiac function was also reported by Lipkin who studied exercise capacity. '3 The mechanism for this was thought to be the delayed recovery of the left atrial booster pump function.
We found that the atrial filling wave measured by pulsed Doppler echocardiography showed gradual increases in peak velocity and the time-velocity integral after cardioversion. This finding accords with data from several other reports." Manning include patients with raised pulmonary wedge pressure in our study. We used late diastolic septal expansion as an indicator of the atrial booster pump function, and this index may be affected by the left ventricular compliance. But it seems unlikely that there were major changes in left ventricular compliance in individual patients during the study period.
CLINICAL IMPLICATIONS
Digoxin is commonly used to reduce the heart rate in patients with atrial fibrillation but it does not improve cardiac function in some patients. Efforts should be made to restore normal sinus rhythm especially in patients with tachycardia and reduced left ventricular filling during atrial fibrillation in pretreat with digitalis. They will greatly benefit from cardioversion by further reduction of heart rate and atrial booster pump fimction. The beneficial effect of cardioversion should be assessed at least a month after cardioversion. 
